Product Information
ATOVAQUONE 750 MG/5 ML SUSP is a generic product labeled by PAI Holdings LLC, priced at $0.7561 per ML under NDC 00121095608. Its NADAC has been published 60 times since Jul 2, 2025.
FDA first approved this application on Oct 25, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121095608
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATOVAQUONEApproval Type
Generic (ANDA)
FDA Application
ANDA214272FDA Approved
10/25/2021
TE Code
AB
On Market Since
4/4/2025
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE 750 MG/5 ML SUSP has been published 60 times since Jul 2, 2025, and over the history we have for it it has declined 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7561 per ML |
|---|---|
| All-time high | $0.8766 (Oct 15, 2025) |
| All-time low | $0.6842 (Jul 22, 2026) |
| 52-week high | $0.8766 |
| 52-week low | $0.6842 |
| Median price | $0.7418 |
| Average price | $0.7661 |
| Largest weekly change | +10.5% (Aug 19, 2026) |
| Weeks tracked | 60 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATOVAQUONE 750 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE 750 MG/5 ML SUSP, manufactured by PAI Holdings LLC, is $0.7561 per ML (NDC 00121095608), effective Aug 19, 2026.
How has the price of ATOVAQUONE 750 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has declined 11.6%. It has been tracked across 60 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE 750 MG/5 ML SUSP?
Since Jul 2, 2025, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has ranged from a low of $0.6842 (Jul 22, 2026) to a high of $0.8766 (Oct 15, 2025), with a median of $0.7418 per ML.
Are there cheaper alternatives to ATOVAQUONE 750 MG/5 ML SUSP?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATOVAQUONE 750 MG/5 ML SUSPENSION CUP, is $0.7418 per ML — about 2% below ATOVAQUONE 750 MG/5 ML SUSP.
Who manufactures ATOVAQUONE 750 MG/5 ML SUSP?
ATOVAQUONE 750 MG/5 ML SUSP (NDC 00121095608) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.